$798 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 22 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PACB | PACIFIC BIOSCIENCES CALIF IN | $44,655,000 | +162.8% | 1,721,459 | 0.0% | 5.60% | +149.9% | |
| SLNO | SOLENO THERAPEUTICS INC | $7,084,000 | -23.1% | 3,670,384 | 0.0% | 0.89% | -26.9% | |
| MOTS | MOTUS GI HLDGS INC | $3,609,000 | -3.0% | 3,806,666 | 0.0% | 0.45% | -7.8% | |
| BIIB | BIOGEN INC | $903,000 | -13.7% | 3,688 | 0.0% | 0.11% | -18.1% | |
| CFRX | CONTRAFECT CORP | $846,000 | -4.4% | 167,587 | 0.0% | 0.11% | -9.4% | |
| BIOL | BIOLASE INC | $725,000 | +51.7% | 1,739,100 | 0.0% | 0.09% | +44.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.